↓ Skip to main content

Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

Overview of attention for article published in Arthritis Research & Therapy, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users
facebook
1 Facebook page

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
88 Mendeley
Title
Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study
Published in
Arthritis Research & Therapy, November 2019
DOI 10.1186/s13075-019-1992-x
Pubmed ID
Authors

Teresa A. Simon, Maarten Boers, Marc Hochberg, Nicole Baker, Mary L. Skovron, Nitesh Ray, Sanket Singhal, Samy Suissa, Andres Gomez-Caminero

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 13%
Student > Bachelor 10 11%
Researcher 9 10%
Other 6 7%
Student > Postgraduate 4 5%
Other 17 19%
Unknown 31 35%
Readers by discipline Count As %
Medicine and Dentistry 29 33%
Pharmacology, Toxicology and Pharmaceutical Science 11 13%
Biochemistry, Genetics and Molecular Biology 6 7%
Nursing and Health Professions 4 5%
Unspecified 3 3%
Other 4 5%
Unknown 31 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2021.
All research outputs
#14,924,082
of 25,387,668 outputs
Outputs from Arthritis Research & Therapy
#2,165
of 3,383 outputs
Outputs of similar age
#193,441
of 381,890 outputs
Outputs of similar age from Arthritis Research & Therapy
#35
of 65 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,383 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,890 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.